XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net loss $ (22,120) $ (37,037)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,904 2,826
Amortization of discount on debt 493 488
Stock-based compensation 10,487 8,962
Allowance for credit losses 1,075 1,313
Changes in operating assets and liabilities:    
Accounts receivable (8,185) (2,502)
Prepaid expenses (4,235) (806)
Deferred commissions 49 (658)
Accounts payable 495 (287)
Accrued and other liabilities (4,922) 5,702
Deferred revenue 3,123 14
Net cash used in operating activities (20,836) (21,985)
Cash flows from investing activities:    
Purchase of property and equipment (1,063) (1,340)
Maturity of marketable securities 39,429 9,000
Purchase of marketable securities (48,043) (32,473)
Net cash used in investing activities (9,677) (24,813)
Cash flows from financing activities:    
Net payment of settlement of equity-based awards (330) 184
Net cash provided by (used in) financing activities (330) 184
Net change in cash and cash equivalents and restricted cash (30,843) (46,614)
Cash and cash equivalents and restricted cash, beginning of period 93,030 298,704
Cash and cash equivalents and restricted cash, end of period 62,187 252,090
Supplemental cash flow information:    
Cash paid for interest 431 472
Cash paid for taxes 152 32
Noncash investing and financing activities:    
Changes in capital additions, accrued but not paid 65 96
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheet to the amounts shown in the statements of cash flows above:    
Cash and cash equivalents 61,070 250,934
Restricted cash 1,117 1,156
Total cash, cash equivalents and restricted cash $ 62,187 $ 252,090